Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15
Published February 19, 2025 · Recall initiated: January 21, 2025
Summary
FDA records drug Class II recall D-0224-2025, published February 19, 2025 and initiated January 21, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 341 cartons; Lot: Lot 45279, Exp 03/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Out of Specification for Dissolution
What to do
Voluntary: Firm initiated · Letter
Get an email if IRBESARTAN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IRBESARTAN
- Manufacturer
- AvKARE
- Distributor
- Nationwide in the USA
- Lot
- Lot 45279, Exp 03/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANestle Toll House Valentine's Chocolate Chip cookie dough, Makes 20 cookies. Net wt 14 oz. UPC 0 28000-34408February 19, 2025
- FDAUNiD" Adaptive Spine Intelligence UNiD Spine Analyzer Product Number SW3002 UDI-DI code 03613720286929 TwoFebruary 12, 2025
- FDAIrbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee-August 3, 2022
- FDAIrbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee-August 3, 2022
- FDAIrbesartan Tablets USP, 150 mg a) 30 count (NDC 68180-411-06) and b) 90 count (NDC 68180-411-09) bottles, RxNovember 10, 2021
- FDAIrbesartan Tablets USP, 75 mg a) 30 count (NDC 68180-410-06) and b) 90 count (NDC 68180-410-09) bottles, RxNovember 10, 2021
Questions about this recall
Was Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15 recalled?
Yes. FDA published recall D-0224-2025 on February 19, 2025. Reported hazard: Out of Specification for Dissolution
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IRBESARTAN.